AVXL
Price
$11.17
Change
-$0.05 (-0.45%)
Updated
Aug 8, 11:58 AM (EDT)
Capitalization
958.38M
4 days until earnings call
RLMD
Price
$0.57
Change
-$0.03 (-5.00%)
Updated
Aug 8, 10:36 AM (EDT)
Capitalization
19.98M
90 days until earnings call
Interact to see
Advertisement

AVXL vs RLMD

Header iconAVXL vs RLMD Comparison
Open Charts AVXL vs RLMDBanner chart's image
Anavex Life Sciences
Price$11.17
Change-$0.05 (-0.45%)
Volume$300
Capitalization958.38M
Relmada Therapeutics
Price$0.57
Change-$0.03 (-5.00%)
Volume$205
Capitalization19.98M
AVXL vs RLMD Comparison Chart in %
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. RLMD commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and RLMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (AVXL: $11.22 vs. RLMD: $0.60)
Brand notoriety: AVXL and RLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 89% vs. RLMD: 22%
Market capitalization -- AVXL: $958.38M vs. RLMD: $19.98M
AVXL [@Biotechnology] is valued at $958.38M. RLMD’s [@Biotechnology] market capitalization is $19.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileRLMD’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • RLMD’s FA Score: 1 green, 4 red.
According to our system of comparison, RLMD is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 3 TA indicator(s) are bullish while RLMD’s TA Score has 3 bullish TA indicator(s).

  • AVXL’s TA Score: 3 bullish, 5 bearish.
  • RLMD’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than RLMD.

Price Growth

AVXL (@Biotechnology) experienced а -0.71% price change this week, while RLMD (@Biotechnology) price change was -3.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.02%. For the same industry, the average monthly price growth was +6.38%, and the average quarterly price growth was +12.34%.

Reported Earning Dates

AVXL is expected to report earnings on Aug 12, 2025.

RLMD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($958M) has a higher market cap than RLMD($20M). RLMD YTD gains are higher at: 15.750 vs. AVXL (4.469). AVXL has higher annual earnings (EBITDA): -45.65M vs. RLMD (-79.12M). AVXL has more cash in the bank: 116M vs. RLMD (27.1M). AVXL has less debt than RLMD: AVXL (88.2K) vs RLMD (256K). AVXL (0) and RLMD (0) have equivalent revenues.
AVXLRLMDAVXL / RLMD
Capitalization958M20M4,790%
EBITDA-45.65M-79.12M58%
Gain YTD4.46915.75028%
P/E RatioN/AN/A-
Revenue00-
Total Cash116M27.1M428%
Total Debt88.2K256K34%
FUNDAMENTALS RATINGS
AVXL vs RLMD: Fundamental Ratings
AVXL
RLMD
OUTLOOK RATING
1..100
6471
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
4041
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
28n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RLMD's Valuation (19) in the null industry is somewhat better than the same rating for AVXL (61) in the Biotechnology industry. This means that RLMD’s stock grew somewhat faster than AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as RLMD (100) in the null industry. This means that AVXL’s stock grew similarly to RLMD’s over the last 12 months.

AVXL's SMR Rating (97) in the Biotechnology industry is in the same range as RLMD (99) in the null industry. This means that AVXL’s stock grew similarly to RLMD’s over the last 12 months.

AVXL's Price Growth Rating (40) in the Biotechnology industry is in the same range as RLMD (41) in the null industry. This means that AVXL’s stock grew similarly to RLMD’s over the last 12 months.

AVXL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RLMD (100) in the null industry. This means that AVXL’s stock grew similarly to RLMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLRLMD
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MITCX33.61N/A
N/A
MFS Massachusetts Investors Tr C
ELDFX22.16N/A
N/A
Elfun Diversified
KTRCX9.28N/A
N/A
DWS Global Income Builder C
AMRCX5.07N/A
N/A
American Growth One C
FIDFX29.29N/A
N/A
Fidelity Advisor Mid Cap Value Z

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
+0.48%
SYRE - RLMD
36%
Loosely correlated
-4.51%
ENTO - RLMD
36%
Loosely correlated
-9.09%
PRTC - RLMD
31%
Poorly correlated
-1.70%
AVXL - RLMD
31%
Poorly correlated
+2.28%
ZVRA - RLMD
29%
Poorly correlated
+5.66%
More